Andersen A N, Pedersen H, Westergaard J G, Schiøler V, Arends J
Acta Obstet Gynecol Scand. 1984;63(2):145-8. doi: 10.3109/00016348409154650.
Serial measurements of serum prolactin (PRL), chorionic gonadotropin (hCG), estradiol and progesterone were performed during 16 normal pregnancies. The same hormone analyses were performed in a woman with the galactorrhea-amenorrhea syndrome and a pituitary adenoma during two pregnancies, with and without continued treatment with bromocriptine throughout gestation. The study indicates that marked differences in circulating PRL levels do not influence the fetoplacental hormone levels. Furthermore, tumor expansion may possibly be prevented and successful breast-feeding can be achieved after treatment with bromocriptine throughout gestation.
在16例正常妊娠期间对血清催乳素（PRL）、绒毛膜促性腺激素（hCG）、雌二醇和孕酮进行了连续测定。对一名患有溢乳-闭经综合征和垂体腺瘤的女性在两次妊娠期间进行了同样的激素分析，一次是在整个妊娠期持续使用溴隐亭治疗，另一次则未使用。该研究表明，循环PRL水平的显著差异不会影响胎盘-胎儿激素水平。此外，在整个妊娠期使用溴隐亭治疗后，可能会预防肿瘤扩大，并实现成功哺乳。
